Company intelligence / Profile preview

BlockRules

California, United States

Ownership: Private
Development stage: Other

Overview

BlockRules is not itself a life science or biotech/pharma company; it is a blockchain fintech/platform provider, specializing in compliance solutions for tokenized securities, primarily serving the healthcare, biotech, and pharma sectors (notably its parent company Verseon). It does not develop therapeutic modalities or drug programs but enables capital formation and investment through technology.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Neuseren S.A.

Beyond the preview

Go deeper on BlockRules.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BlockRules.

Explore the full profile